Product Code: ETC4538006 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The Thailand Human Milk Oligosaccharides (HMO) Market is focused on infant nutrition. HMOs, naturally found in breast milk, are used in infant formula to provide health benefits similar to breastfeeding, addressing the needs of newborns and infants.
The Human Milk Oligosaccharides (HMO) market in Thailand is experiencing significant growth, driven by the increasing recognition of HMOs as functional ingredients with potential health benefits. HMOs, naturally occurring compounds in human breast milk, are now being incorporated into infant formula and other nutritional products due to their prebiotic effects and potential to support infant gut health and immune development. The market expansion is further propelled by Thailand focus on early childhood nutrition, the growing awareness of the importance of breastfeeding alternatives, and the pursuit of scientifically backed ingredients for infant formula. As Thailand nutritional industry aims to provide innovative and beneficial solutions for infant health, the demand for HMOs is on the rise, marking a strategic shift towards improving the nutritional profile of infant nutrition products.
In the human milk oligosaccharides (HMO) market, challenges emerge from the need for extensive research and development to mimic the complexity and functionality of natural HMOs. Companies must invest in cutting-edge technologies to produce high-quality HMOs for infant formula and functional food applications.
The COVID-19 pandemic impacted the Thailand Human Milk Oligosaccharides (HMO) Market, causing disruptions in the infant formula and nutritional supplement industry. The restrictions on movement and uncertainties in the market affected product launches and marketing efforts. However, post-pandemic, the market witnessed a resurgence as the demand for advanced infant nutrition solutions increased. Increased interest in HMOs for their potential health benefits contributed to the recovery of the HMO Market.
The Thailand Human Milk Oligosaccharides (HMO) Market features companies such as Glycosyn LLC, Jennewein Biotechnologie GmbH, and DuPont de Nemours, Inc. These players contribute to the production of HMOs for infant formula, aiming to replicate the nutritional benefits of human breast milk.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Human Milk Oligosaccharides (HMO) Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 Thailand Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 Thailand Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Human Milk Oligosaccharides (HMO) Market Trends |
6 Thailand Human Milk Oligosaccharides (HMO) Market, By Types |
6.1 Thailand Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2� Fl, 2021-2031F |
6.1.4 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3� Fl, 2021-2031F |
6.1.5 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3� Sl, 2021-2031F |
6.1.6 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6� Sl, 2021-2031F |
6.2 Thailand Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021-2031F |
6.2.3 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021-2031F |
6.2.4 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021-2031F |
6.3 Thailand Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021-2031F |
6.3.3 Thailand Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021-2031F |
7 Thailand Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 Thailand Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 Thailand Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 Thailand Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
9 Thailand Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 Thailand Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 Thailand Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 Thailand Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 Thailand Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |